Hepatitis C: When high drug prices preclude patient benefit

Currently, there are at least 6 drug companies that have developed curative treatments for hepatitis C. Drugs that cure hepatitis C can save up to one‐half million individuals every year, but these therapies are neither accessible nor affordable. See also pages 000‐000.
Source: Cancer - Category: Cancer & Oncology Authors: Tags: Commentary Source Type: research